Description
Wiley Sarcopenia 2021 Edition by Alfonso J. Cruz-Jentoft ,John E. Morley
SARCOPENIAAn in-depth examination of sarcopenia?s underexplored yet widespread impact within the field of gerontologySarcopenia is common in older men and women, and yet awareness of its clinical relevance is still relatively low. Only formally included in the International Classification of Diseases in 2016, the condition may impact societies with serious health-related and financial consequences unless consistent, effective methods of identification and management are adopted.This second edition of Sarcopenia provides geriatricians and other healthcare professionals with a revised and expanded examination of this understudied and underdiagnosed condition. Edited by two leading authorities on the subject, it covers the epidemiology and diagnosis of sarcopenia, as well as treatment options and possible prevention strategies. Eight newly written chapters build upon existing knowledge with fresh data on topics including sarcopenia?s biomarkers and its impact on the healthcare economy. This important text: Defines sarcopenia and explains its clinical relevanceCovers all recent scientific evidenceOutlines treatment optionsConsiders prevention strategiesDiscusses sarcopenia as a public health priorityFeatures eight new chapters covering topics such as sarcopenia?s clinical management, its biomarkers, and its financial impact Containing vital information for clinicians and other professionals working in geriatric care, nursing homes, nutrition, cancer, endocrinology, surgery, sports medicine and many other specialties, Sarcopenia, second edition, is a groundbreaking and essential new resource. Table of Contents : Preface1 Definitions of Sarcopenia2 Epidemiology of Muscle Mass Loss with Age3 The Role of Mitochondria in Muscle Function4 Motor unit remodelling5 Nutrition, Protein Turnover and Muscle6 Screening for Sarcopenia7 Adverse Outcomes and Functional Consequences of Sarcopenia8 A Lifecourse Approach to Sarcopenia9 Acute Sarcopenia10 Sarcopenia, Frailty and Intrinsic Capacity11 Osteosarcopenia12 Sarcopenic Obesity13 Sarcopenia and Cognition14 Sarcopenia and Other Chronic Organ Diseases15 Imaging of Skeletal Muscle16 Measurements of Muscle Mass, Equations and Cut-off Points17 Deuterated creatine dilution to assess muscle mass (D3Cr muscle mass) in humans: methods, early results and future directions18 Measurement of Muscle Strength and Power19 Measurements of Physical Performance20 Biomarkers for Physical Frailty and Sarcopenia: a "Two-Body Problem"21 Quality of Life and Sarcopenia22 Exercise Interventions to Prevent and Improve Sarcopenia23 Nutritional Approaches to Treat Sarcopenia24 Beta-hydroxy-beta-methylbutyrate (HMB) and Sarcopenia25 The Future of Drug Treatments26 Sarcopenia: Is It Preventable?27 Financial Impact of Sarcopenia28 Sarcopenia Management For Clinicians